Document is current
Any future updates will be listed below
-
Authors
Verma, Madhur https://orcid.org/0000-0002-1787-8392
Kalra, Sanjay https://orcid.org/0000-0003-1308-121X
Deepa, Mohan https://orcid.org/0000-0001-6348-1946
Venkatesan, Ulagamadesan https://orcid.org/0000-0002-1638-6046
Sharma, Nikita https://orcid.org/0000-0003-3242-2366
Pradeepa, Rajendra https://orcid.org/0000-0002-4909-3733
Chauhan, Kirti https://orcid.org/0000-0002-6208-9229
Singh, Omna
Elangovan, Nirmal
Aggarwal, Sameer
Kakkar, Rakesh
Dhaliwal, R. S.
Kaur, Tanvir
Mohan, Viswanathan https://orcid.org/0000-0001-5038-6210
Anjana, Ranjit Mohan https://orcid.org/0000-0002-4843-1374
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 7 April 2025
First Online: 13 May 2025
Declarations
:
: Sanjay Kalra is an Editorial Board member of Advances in Therapy. Sanjay Kalra was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. The other authors (Madhur Verma, Mohan Deepa, Ulagamadesan Venkatesan, Nikita Sharma, Rajendra Pradeepa, Kirti Chauhan, Omna Singh, Nirmal Elangovan, Sameer Aggarwal, Rakesh Kakkar, RS Dhaliwal, Tanvir Kaur, Viswanathan Mohan, and Ranjit Mohan Anjana) have nothing to disclose.
: The survey was ethically approved by the Institutional Ethics Committee of Madras Diabetes Research Foundation vide letter number MDRF/NCT/02-08/2018, dated 2 March 2018. Formal permissions were taken from the state health authorities before the survey initiation. Informed consent was taken from all the participants before initiating the interview and drawing their blood samples. All participants with abnormal biochemical profiles were ensured the standard of care by linking them to the nearest government health centre pre-defined in the protocols. The original survey was conducted in accordance with the Declaration of Helsinki.
